News > EHA 2020 > PODCAST: prof. dr. Michel Delforge about the KarMMa trial

PODCAST: prof. dr. Michel Delforge about the KarMMa trial

June 2020 EHA 2020 Marjolein Groot

In this podcast prof. dr. Michel Delforge talks about the results regarding quality of life of patients with relaps or refractory multiple myeloma, who were treated with CAR-T cell therapy in the KarMMa trial.

Share this article

Accelerating CAR-T cell therapy for cancer patients

Clinical trials

LISO-CEL SHOWS SUPERIOR EFFICACY VS. STANDARD OF CARE AS SECOND-LINE TREATMENT FOR PRIMARY REFRACTORY OR EARLY RELAPSED LBCL

Health Innovation

Loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma

Top